BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
1059 results:

  • 1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
    Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evidence of promoting effects of 6:2 Cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health?
    Hong J; Du K; Jin H; Chen Y; Jiang Y; Zhang W; Chen D; Zheng S; Cao L
    Environ Int; 2024 Apr; 186():108582. PubMed ID: 38513556
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Activation of the pi3k/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
    Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
    Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.
    Dong Z; Chong W; Chen C; Qi L; Mengke L; Minghui D; Jiawei Y; Longxi Q; Hengchao L; Liu J; Zhimin G
    BMC Cancer; 2024 Mar; 24(1):286. PubMed ID: 38439030
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, pi3k, EMT pathways and tumor progression.
    Zhao C; Li X; Zhang R; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
    Biomed Pharmacother; 2024 Apr; 173():116372. PubMed ID: 38432129
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glycolysis-non-canonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment.
    Qiao J; Liu S; Huang Y; Zhu X; Xue C; Wang Y; Xiong H; Yao J
    J Colloid Interface Sci; 2024 Jul; 665():477-490. PubMed ID: 38429120
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRAS
    Tan YQ; Sun B; Zhang X; Zhang S; Guo H; Basappa B; Zhu T; Sethi G; Lobie PE; Pandey V
    Cell Death Dis; 2024 Feb; 15(2):173. PubMed ID: 38409090
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients.
    Zhu W; Yang L; Gao Y; Zhou Y; Shi Y; Liu K; Yu R; Shao Y; Zhang W; Wu G; He J
    Genomics; 2024 Mar; 116(2):110808. PubMed ID: 38364976
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus.
    Zhou D; Xu W; Ding X; Guo H; Wang J; Zhao G; Zhang C; Zhang Z; Wang Z; Wang P; Lu L; Yuan M
    Cancer Sci; 2024 Apr; 115(4):1129-1140. PubMed ID: 38351514
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of bio-flavonols and their derivatives in improving mitochondrial dysfunctions associated with pancreatic tumorigenesis.
    Sharma V; Arora A; Bansal S; Semwal A; Sharma M; Aggarwal A
    Cell Biochem Funct; 2024 Jan; 42(1):e3920. PubMed ID: 38269510
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro.
    Huang YP; Yeh CA; Ma YS; Chen PY; Lai KC; Lien JC; Hsieh WT
    Environ Toxicol; 2024 May; 39(5):2768-2781. PubMed ID: 38264921
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated pi3k/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms.
    Gu D; Ye M; Zhu G; Bai J; Chen J; Yan L; Yu P; Lu F; Hu C; Zhong Y; Liu P; He Q; Tang Q
    J Transl Med; 2024 Jan; 22(1):93. PubMed ID: 38263056
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NUDT21 interacts with NDUFS2 to activate the pi3k/AKT pathway and promotes pancreatic cancer pathogenesis.
    Huang XD; Chen YW; Tian L; Du L; Cheng XC; Lu YX; Lin DD; Xiao FJ
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):8. PubMed ID: 38195952
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of Rictor alterations in gastrointestinal tumors (Review).
    Cao R; Guo S; Min L; Li P
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186315
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
    Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
    Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.
    Ma Z; Gu Q; Dai Y; Wang Q; Shi W; Jiao Z
    Cancer Sci; 2024 Mar; 115(3):820-835. PubMed ID: 38151993
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma.
    Zhang B; Guo X; Huang L; Zhang Y; Li Z; Su D; Lin L; Zhou P; Ye H; Lu Y; Zhou Q
    Br J Cancer; 2024 Mar; 130(4):542-554. PubMed ID: 38135712
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 53.